The nucleus represents a cellular control unit that regulates all events concerning the storage and processing of DNA and RNA. It is organized by highly crowded, dynamic assemblies of proteins and nucleic acids in molecular machines, ribonucleoprotein complexes, clusters of ongoing nuclear processes, nuclear bodies, and chromatin. This review discusses the occurrence of nuclear protein aggregation with special emphasis on the functional architecture of the nucleus, and quality control by the ubiquitin-proteasome system. Keywords: Amyloid, gene expression, Huntington's disease, neurodegeneration, nucleus, polyglutamine, protein aggregation, trinucleotide repeat, ubiquitin-proteasome system.
While genomes are defined by their primary sequence the key question that emerged after recent sequencing of organisms, including Homo sapiens, is how genome function is integrated into the architectural framework of the cell nucleus. The prevalent concept is that many of these subdomains are associated with specific genetic loci and that interactions between various domains are dynamic and can change in response to cellular signals [5] [6] [7] . A dynamic protein exchange occurs between nuclear domains and the surrounding nucleoplasm with exchange rates that depend on the functional activity of a nuclear protein and / or its participation in ribonucleoprotein complexes. Thus, the functional status of exchanging proteins critically determines the composition and morphology of subnuclear compartments [8] . A paradigm for nuclear structure function relationships is the nucleolus that forms by clustering of the RNA-polymerase Idependent transcription machinery at tandem repeats of ribosomal DNA in the so-called nucleolus organizer regions (NORs) during the start of interphase thereby initiating the *Address correspondence to this author at the Institut fuer umweltmedizinische Forschung (IUF) at Heinrich-Heine-University Düsseldorf, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany; Tel: ++49-211-3389-358; E-mail: mikecz@tec-source.de; Web: www.tec-source.de/mikecz synthesis of ribosomal RNA, and disaggregates at the start of mitosis [1] . Nucleolar decomposition is also observed as a direct consequence of inhibition of RNA polymerase I, e.g. ribosomal RNA transcription, by xenobiotics [1, 9] .
The structural dynamics of subnuclear compartments such as the nucleolus and nuclear bodies seem to allow for functional flexibility, but this flexibility requires regulation. Hundreds of macromolecules including chromatin modulators, transcription factors, nuclear receptors and ribonucleoprotein particles (RNPs), cluster to form the molecular machineries for replication, DNA repair, transcription, RNA splicing, and ribosome biogenesis. How are these clusters disassembled and turned off in order to enable the sequential steps in gene expression to proceed? This question is further complicated by the fact that macromolecules in the nucleus are highly concentrated (approximately 100 mg/ml) which is likely to cause strong crowding forces. While molecular crowding may represent the mechanism of nuclear compartment formation [10, 11] , it may at the same time promote formation of aberrant and insoluble protein aggregates in the nucleoplasm [12] . Consistent with this idea it is important to note that fibrillation-prone proteins containing homopeptide repeat stretches such as polyglutamine (polyQ) are essential components of macromolecular complexes that sustain gene expression as well as aberrant nucleoplasmic protein aggregates ( Fig. (1) ; [13] [14] [15] ). The transcription initiation complex includes proteins with unexpanded polyQ repeats that function as transcriptional co-activators, transcription factors, nuclear receptors, and general transcription factors.
THE UBIQUITIN-PROTEASOME-SYSTEM PARTICI-PATES IN NUCLEAR FUNCTION
A growing body of evidence indicates that the ubiquitin proteasome system (UPS) is intimately involved in gene expression control at the transcription level and quality control in the cell nucleus [16] [17] [18] [19] . In eukaryotic cells, a large ATPdependent proteolytic machine, the 26S proteasome [20] , prevents accumulation of non-functional, potentially toxic proteins. The 26S proteasome is a self-compartmentalized multisubunit protease complex that degrades substrates which are post-translationally tagged by a polyubiquitin chain [20] . The 26S proteasome is composed of a 20S catalytic core and two flanking 19S regulatory complexes constituting the structure 19S-20S-19S. According to the current conception polyubiquitinated proteins are (i) recognized by the 19S regulatory subunits, (ii) unfolded, (iii) channeled via a central passageway into the degradation chamber, (iv) degraded into peptides, and (v) released through the entry channel [21] . The polyubiquitinated substrates seem to allosterically activate proteasomal degradation by binding to the 19S regulator, which in turn induces stabilization of gate opening and facilitation of substrate entry into the proteolytic chamber [22] .
Dynamic nuclear processes have to be regulated and controlled in order to maintain the function of the nucleus throughout interphase. More than twenty years ago, Franke and colleagues observed that proteasomes localize to the nuclei of Xenopus laevis oocytes and HeLa cells [23, 24] . Varshavsky and co-workers showed that ubiquitin-dependent pathways play a role in cell cycle control and suggested that protein degradation is instrumental in regulation of gene expression [25] . The following decades brought about confirmation that components of the UPS indeed reside in the cell nucleus and that nuclear proteins are substrates for proteasomal degradation. However, export of nuclear proteins to the cytoplasm was considered to be required for their degradation. Prominent examples include the tumor suppressor p53 and cyclin-dependent kinase (CDK) inhibitor p27 [26] [27] [28] . Thus, research predominantly concentrated on cytoplasmic protein breakdown showing that this generates peptides for antigen presentation [29] and removes the bulk of newly synthesized, defective ribosomal products (DRIPs, [30, 31] .
Recent work suggests direct engagement of a nuclear UPS (nUPS) in DNA repair, replication, transcription, and nuclear quality-control [13, 15, 18, [32] [33] [34] [35] [36] . Proteasomal activity is localized in subnuclear compartments such as speckles, PML NBs and distinct proteolytic foci in euchromatic regions [15, 36, 37 ; Scharf and von Mikecz, unpublished results]. Proteasomal proteolysis in loosely packed euchromatin is consistent with the idea of an interaction of a nUPS with nuclear processes. Indeed, ubiquitin and the proteasome system are intimately involved in the regulation of gene expression control at the transcription level. The yeast transcription factor Gcn4 binds to a cognate promoter region, activates Gcn4-responsive genes and is subsequently marked for destruction by SCF Cdc4 , the ubiquitin ligase for Gcn4. These events suggest that proteolysis is required to remove "spent" activators in order to reset the promoter. Indeed, degradation of Gcn4 and the transcriptional activators Gal4 and Ino2/4 by the UPS stimulates expression of their targets. Moreover, studies have shown mutations in SCF Cdc4 and mutations in ubiquitin that prevent proteolysis also impair the transcription of Gcn4 targets [38] , confirming this idea. While a physical association with active transcription sites has not been observed during initiation and elongation [39; Scharf and von Mikecz, unpublished], it could be shown that proteasomes recruit to sites of stalled transcription machineries due to UV-induced DNA damage [40] . In contrast to fluorescence recovery after photobleaching (FRAP) analyses with ectopically expressed proteasomal subunit LMP2 that suggested a high mobility of proteasomes in the nucleus [41] , proteasomal proteolytic activity seems to be localized to confined nuclear loci that partially overlap with nuclear subcompartments [36, 42] , and are generally immobile (Scharf and von Mikecz, unpublished).
In summary, it is now well established that the UPS is not only present in the nucleus, but an active player in nuclear processes. Compartmentalized proteolysis allows cells to regulate degradation of specific proteins by control of their subcellular localization. A tuned balance of ubiquitination and proteasome-dependent protein degradation of nuclear poteins in distinct nucleoplasmic proteolysis factories may be instrumental in nuclear function and, when deregulated, lead to abnormal protein aggregation in the cell nucleus. Aberrant nuclear protein aggregation may in turn be involved in the development of protein aggregation diseases such as polyglutamine disorders and other neurodegenerative conditions.
NUCLEAR PROTEIN AGGREGATES: OCCURENCE
If a native protein is damaged it generally converts to a misfolded conformation. Such a misfolded protein may be subjected to (i) chaperone-mediated refolding back into the native conformation, (ii) ubiquitination and subsequent degradation by the proteasome, (iii) cleavage and nucleocytoplasmic transport, or (iv) protein aggregation [19] . [46] [47] [48] [49] .
The toxic role of protein aggregates has been deduced from the fact that they are microscopically discernible in numerous neurodegenerative diseases. Cytoplasmic Lewy bodies were discovered in patients with Parkinson's disease as early as the beginning of the 20th century [16] . Likewise, extracellular plaques and intracellular tangles occur in Alzheimer's, whereas polyglutamine disorders are characterized by cytoplasmic and nuclear inclusions. Polyglutamine disorders represent a subset of trinucleotide repeat diseases in which proteins with unstable, expanded homopolymeric amino acid repeats accumulate in distinct subcellular domains [50] . A hallmark of the most widely known polyglutamine disorder Huntington's disease (HD) is the cytoplasmic and nucleoplasmic aggregation of the gene product huntingtin, a 348 kDa protein with unknown function. Spinocerebellar ataxias (SCAs) are characterized by nuclear inclusions of ataxin proteins or TATA box binding protein (TBP) with expanded polyglutamine repeats. Finally, in spinal and bulbar muscular atrophy (SBMA) mutant androgen receptor is accumulated in the cytoplasm and nucleoplasm [49, 51] .
NUCLEAR PROTEIN AGGREGATES: COMPOSI-TION
The main components that have been identified in nuclear protein aggregates include (i) proteins with instable, elongated trinucleotide repeats, (ii) proteins with trinucleotide repeats of normal length, (iii) elements of the UPS, (iv) heat shock proteins, and (v) proteins that normally localize to subnuclear domains such as the nucleolus, speckles, Cajal NBs and PML NBs (for a comprehensive listing see supplemental material of [15] ). System biology-based approaches demonstrate that the polyglutamine protein huntingtin interacts amongst others with general transcription factor TBP, histone acetylase CREB binding protein, transcription factor SP1, histone acetylase HDAC1, and the signature protein of PML NBs PML, thus building an elaborate interactome [52] . While it is not clear whether all these interactions are of functional significance, it is important to note that components of this protein network are also components of nuclear protein aggregates [15] .
Consistent with the idea of dynamic nuclear structures it was shown by fluorescence imaging of living cells that proteins which participate in nuclear protein inclusions such as molecular chaperones are not irreversibly sequestered into aggregates, but rather transiently associated [53] . In analogy to other dynamic subdomains of the nucleus exchange of inclusion components might depend on the functional status of the proteins and / or the aggregate (see above). Thus, chaperones could represent active and therefore transient passengers through nuclear protein aggregates. Since polyglutamine-induced inclusions form by sequential steps of amyloid-species such as small soluble aggregates, protofibrils, and mature fibrils [54, 55] the dynamics of protein components may likewise depend on the progression of the aggregate structure. Small, amorphous aggregates may still provide the physicochemical conditions for component exchange, whereas mature amyloid fibrils or their accumulation in plaques may be characterized by irreversible protein sequestration.
Formation of amyloid-like intranuclear inclusions is experimentally inducible by addition of silica-nanoparticles (NPs) to cells in culture [13, 15] . These nuclear protein aggregates exactly mimic their polyglutamine-induced counterparts with respect to biochemical properties and protein composition. Silica-NP-induced nuclear inclusions (i) stain with Congo red and thioflavin T, (ii) are insoluble as analysed by filter binding assays and density gradient centrifugation, (iii) and can be reduced by Congo red and trehalose [15; Chen and von Mikecz, unpublished]. As an advantage versus other experimental systems protein aggregation by nanoparticles allows for the characterization of endogenous aggregate components with a functional UPS in place. Thus, the silica-NP-induced inclusions contain polyglutamine proteins huntingtin, ataxin-3, TBP, and CREB binding protein, components of the UPS, and nuclear proteins such as fibrillarin, topoisomerase I, p80 coilin, and PML that are normally localized in nucleoli, Cajal NBs and PML NBs, respectively. Detailed localization by confocal microscopy shows that polyglutamine proteins occur in the center, whereas other nuclear proteins and proteasomes accumulate at the periphery of silica-NP-induced nuclear inclusions (Fig. 2) . A similar aggregate morphology was reported in vitro and in vivo showing aggregated polyglutamine proteins engulfed in a coat of PML protein and close to Cajal NBs [56, 57] . Localization of proteasomal activity revealed that one third of nanoparticle-induced protein aggregates are proteolytically active and that 90% of this subpopulation colocalized with PML [15] .
NUCLEAR PROTEIN AGGREGATES: PROTEO-LYTIC CENTERS
A role for PML NBs in removal of excess and or misfolded proteins has been initially proposed for viral proteins. Yewdell and coworkers showed accumulation of mutated forms of influenza virus in PML NBs after inhibition of proteasome-dependent protein degradation [58] .
Due to viral nucleoprotein-induced recruitment of proteasomes and molecular chaperones to PML NBs the authors suggested that these NBs serve as proteolytic centers in the nucleus. But which features would make PML NBs suited as sites of protein degradation? PML NBs are amorphous, spherical structures that can be localized by a variety of microscopical methods. To date approximately 78 protein components have been assigned to PML NBs [59; nuclear protein database: http://npd.hgu. mrc.ac.uk/index.html] with PML and Sp100 representing constitutive signature proteins, and Daxx, small ubiquitinlike modifier SUMO, Bloom syndrome gene product BLM and NDP55 present at endogenous expression levels. In contrast to nucleoli and Cajal NBs, PML NBs do not contain DNA or RNA, and are consistently devoid of ribonucleoprotein complexes. PML NBs are dynamic subnuclear domains that alter their number, size and components in response to diverse environmental stimuli such as viral infections, extracellular signalling, and genotoxic stress. However, under normal growth conditions a typical mammalian nucleus contains between 10 to 30 PML NBs sized between 0.3 and 1.0 μm [60] . The residence times of PML, Sp100 and other components in their respective PML NB may last from several seconds to 1 hour [61] suggesting a constant exchange of constituents between the NB and the surrounding nucleoplasm. In contrast to its components the PML NB itself appears to be mostly static due to extensive contact to chromatin. A small and mobile subpopulation of PML NBs has been identified and it was suggested to function as a sensor that detects foreign and misfolded proteins, including viral proteins and protein aggregates [62] .
The dynamic properties of their constituents and a subpopulation of the NBs together with results indicating colocalization of PML NBs with the UPS lead to the following hypothesis: PML NBs might detect foreign and / or misfolded proteins and promote their degradation by proteasomes. Consistent with this idea it was shown that the degradation of PML is correlated to colocalization between PML NBs and proteasomes [37] , degradation of a fluorescent model substrate can be partially localized at PML NBs [36] , and the majority of silica-NP-induced protein aggregates which are proteolytically active are coated by PML in a ring-shaped pattern [15] . The model of PML NBs as proteolytic centers is made even more appealing by the observation that overexpressed proteins regularly form nuclear protein aggregates and colocalize with PML [4, 63] .
An interaction between PML NBs and protein aggregation was observed in vivo and in vitro. In the brains of patients with spinocerebellar ataxia 7, and respective mouse models mutated ataxin 7 (with an expanded polyglutamine tract) colocalized with PML NBs [64, 65] . Consistent with a protective, proteolytic role it was shown that PML NBs are associated with early steps of polyglutamine-associated amyloid formation [64] . In cell culture models expression of mutant ataxin-1 and -3 induced aberrant distribution of PML in the nucleus [66] . In reverse, overexpression of PML isoform IV promoted the formation of NBs enriched in UPS components [65] . Such NBs recruited ataxin-7, but prevented formation of insoluble protein aggregates by proteasomedependent proteolysis. Together with results that detect PML in proteolytically active nuclear inclusions [15] a picture emerges where PML NBs may serve as proteolytic centers for misplaced and / or misfolded proteins in the cell nucleus, thus preventing further steps of protein aggregation which would eventually give rise to insoluble, irreversible inclusions. The dynamic nature of PML NBs with respect to their protein components, and the lack of ribonucleoprotein complexes may allow for a promiscuous and continuous exchange of potential proteasome substrates. Thus, PML NBs may at the same time be proteolytic centers and nuclear protein aggregates depending on the definition and foremost on a fine tuned regulation by the UPS, e.g. proteasomedependent proteolytic activity. 
PERSPECTIVES
Protein aggregation in the cell nucleus seems to occur spontaneously in brains of patients with neurodegenerative triplet repeat diseases and respective animal models. In cell culture nuclear protein inclusions can be induced by environmental stressors, including silica-NPs. From cell-based models we may learn more about the molecular mechanisms and the role of protein aggregation. Recent results indicate that nucleoplasmic protein aggregates are not simply "junkyards" for excess and / or misfolded protein species. The UPS acts by means of proteasome-dependent protein degradation in one third of these "junkyards". Due to the dynamic and crowded topology of the nucleus that is required for processes such as transcription, functional multiprotein complexes (Fig. 1) may always be prone to aggregation, and without regulation by proteasomal proteolysis in danger to undergo the serial steps of polyQ fibrillation (Fig.  3) . Thus, a functional nuclear ribonucleoprotein cluster may resemble a protein aggregate in protein composition, but differ in its proteasomal activity. Likewise, the presence of molecular chaperones may decide the fate of nuclear protein aggregates. Towards a better understanding of nuclear protein aggregation and its anticipated biological function we need more systematic approaches to identify aggregate component networks in correlation to both, detailed analysis of the biophysical protein fibrillation (or amyloid) status and activity of the UPS (Fig. 3) . Development of relevant nuclear substrates for proteasomal degradation will be instrumental to pinpoint proteolytic centers, including protein aggregates, and determine their influence on neurons as well as neurodegeneration. An equally important goal in order to elucidate the pathogenesis of neurodegenerative polyglutamine diseases is a better understanding of amyloidogenesis in the environment of the nucleus.
